PEMGX
Price
$37.76
Change
+$0.33 (+0.88%)
Updated
Sep 11 closing price
Net Assets
21.28B
SENAX
Price
$50.69
Change
-$0.30 (-0.59%)
Updated
Sep 11 closing price
Net Assets
597.49M
Interact to see
Advertisement

PEMGX vs SENAX

PEMGX vs SENAX Comparison Chart in %
View a ticker or compare two or three
VS
PEMGX vs. SENAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEMGX is a Hold and SENAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 21.3B vs. SENAX (597M). PEMGX (0.00) and SENAX (0.00) have matching dividends . PEMGX was incepted earlier than SENAX: PEMGX (21 years) vs SENAX (27 years). SENAX (1.24) is less costly to investors than PEMGX (0.90). SENAX is a more actively managed with annual turnover of: 69.00 vs. PEMGX (13.70). SENAX (6%) and PEMGX (6%) have equivalent initial investment costs. PEMGX (1000) and SENAX (1000) have matching initial minimum investment requirements. SENAX annual gain was more profitable for investors over the last year : -10.32 vs. PEMGX (-19.11). PEMGX return over 5 years is better than : -9.00 vs. SENAX (-38.17).
PEMGXSENAXPEMGX / SENAX
Total Expense Ratio0.901.1876%
Annual Report Gross Expense Ratio0.901.2473%
Fund Existence21 years27 years-
Gain YTD-8.1023.398-238%
Front Load6%6%96%
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets21.3B597M3,568%
Annual Yield % from dividends0.000.00-
Returns for 1 year-19.11-10.32185%
Returns for 3 years9.3221.6643%
Returns for 5 years-9.00-38.1724%
Returns for 10 years71.7822.64317%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POET7.950.35
+4.61%
POET Technologies
ESLA0.690.02
+3.09%
Estrella Immunopharma
BLDR60.371.40
+2.37%
Builders FirstSource
CUB10.880.02
+0.18%
Lionheart Holdings
NVO43.07-0.94
-2.14%
Novo-Nordisk A/S